MR编号 | UK/H/6568/006 | ||||||
---|---|---|---|---|---|---|---|
药品名称 | Abstral 800 microgram sublingual tablets | ||||||
活性成分 |
| ||||||
剂型 | Sublingual tablet | ||||||
上市许可持有人 | Head Of Regulatory Affairs ACTAVIS UK LIMITED WHIDDON VALLEY BARNSTAPLE EX32 8NS UNITED KINGDOM | ||||||
参考成员国 - 产品名称 | United Kingdom (GB) | ||||||
互认成员国 - 产品名称 | |||||||
许可日期 | 2019/05/14 | ||||||
最近更新日期 | 2019/05/29 | ||||||
药物ATC编码 |
申请类型 | 附件文件下载 | 市场状态 | Withdrawn(注:已撤市) | 撤市原因:1.The company decided to withdraw the application. At the time of withdrawal, the MS considered that the data provided did not allow to conclude on a positive benefit-risk balance as major objections were raised. |